Discover 1,803 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,803
Featured
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
for
Atherosclerosis
Location: Chapel Hill NC, Pittsburgh PA, Nashville TN,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07448038
Phase2, Recruiting
Featured
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for
Parkinson's Disease
Location: Durham NC, Charlottesville VA, Asheville NC,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07174310
Phase3, Recruiting
Featured
Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
for
Migraine
Location: Durham NC, Ottawa
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT05158894
Recruiting
Featured
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
for
Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment,
Location: Morrisville NC
Sponsor: AbbVie
Sex: Female
Age: 0+
Code: NCT04846959
Recruiting
Active & Responsive
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
for
Human Immunodeficiency Virus (HIV),
Location: Greensboro NC, Chapel Hill NC, Columbia SC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16+
Code: NCT07044297
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Location: Greensboro NC, Charlotte NC, Washington D.C. DC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07266831
Phase2, Phase3, Recruiting
Active & Responsive
Clinical Evaluation of WaveLight Plus LASIK
for
Myopia, Astigmatism
Location: Greensboro NC
Sponsor: Laser Defined Vision
Sex: All
Age: 18+
Code: NCT07127757
Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
for
Percutaneous Coronary Intervention,
Location: Greensboro NC, High Point NC, Winston-Salem NC,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06909565
Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Location: Greensboro NC, Winston-Salem NC, Lynchburg VA,
Sponsor: EyeBiotech Ltd.
Sex: All
Age: 50+
Code: NCT07440225
Phase2, Phase3, Recruiting
Active & ResponsiveNew
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
for
Overweight, Obesity
Location: Greensboro NC, Richmond VA, Wilmington NC,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07745504
Phase3, Recruiting
Active & Responsive
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
for
Obesity
Location: Greensboro NC, Chapel Hill NC, Wilmington NC,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07339423
Phase3, Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for
HIV Infections
Location: Greensboro NC, Lynchburg VA, Washington D.C. DC,
Sponsor: ViiV Healthcare
Sex: All
Age: 12+
Code: NCT07650916
Phase3, Recruiting
Active & Responsive
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
for
Overweight, Obesity
Location: Greensboro NC, Danville VA, Monroe NC, New Bern NC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07589608
Phase2, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
for
Obesity, Overweight and/or Obesity, Overweight
Location: Greensboro NC, Louisville KY, Wilmington NC, Norfolk VA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07595549
Phase3, Recruiting
Active & Responsive
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
for
Obesity
Location: Greensboro NC, Wilmington NC, Winchester VA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07503210
Phase3, Recruiting
Active & Responsive
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
for
Obesity, Overweight
Location: Greensboro NC, Danville VA, Monroe NC, New Bern NC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06143956
Phase2, Recruiting
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Greensboro NC, Reidsville NC, Chapel Hill NC,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase2, Recruiting
Active & Responsive
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier